OGN — Organon & Co.
Unknown Industry · Unknown Sector
S&P 500 Timeline
2021-06-03Joined S&P 500
2023-10-18Removed from S&P 500
Organon & Co. is a global healthcare company with a mission to deliver efficient medicines and solutions to守护日常健康 (maintain daily health). Its business includes the following product portfolios: Women's Health portfolio, with women's health prescription products primarily covering two therapeutic areas - contraception (core brand Nexplanon) and fertility (core brand Follistim), while other women's health products include Jada, used for conservative treatment of postpartum abnormal uterine bleeding or major bleeding; and General Medicines portfolio, including biosimilars and mature brand drugs. The company's current biosimilar portfolio covers immunology and oncology-related therapeutic areas.
Key Facts
| Status | Active |
| Sector | Unknown Sector |
| Industry | Unknown Industry |
| Joined | 2021-06-03 |
| Tenure | 2 yrs |
Industry Peers
—
Sector Peers
—
Data source:
Wikipedia · CC BY-SA 4.0 · Updated 2026-07-10